15 results
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of ... Treatment Agents ... 4/11/2020 #Drugs ... #COVID19 #Pharmacology ... #Table #Management
Drugs Used for the Treatment of COVID-19 Infection
LOPINAVIR / RITONAVIR
INTERFERON Beta-I
REMDESIVIR
HYDROXYCHLOROQUINE
TOCILIZUMAB

Piotr Okupski @PiotrOkupski - Original Infographic
Drugs Used for the ... Treatment of COVID ... -19 Infection LOPINAVIR ... #COVID19 #Pharmacology ... #Table #Management
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Drugs for Treatment ... #MDRTB #management ... #pharmacology # ... dosing #idsa #drugs
COVID-19 review…here is a list of some of the drugs that are currently being used or
COVID-19 review… ... of some of the drugs ... here are the 4 drug ... #Management #Pandemic ... Pharmacotherapy #Pharmacology
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
options in REBEL Review ... Medications #management ... #covid19 #treatment ... sedative #analgesia #pharmacology ... #alternatives #Drugs
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the ... Treatment of COVID ... -19 Infection ... #COVID19 #Pharmacology ... #Table #Management
Flutycosine - Antibiotics Class Overview
 - 
Mechanism: 5-FC interferes with DNA and protein synthesis.  Only
Antibiotics Class Overview ... B for initial management ... - Drug levels ... #Pharmacology #Antibiotics ... #Review #Overview
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... are contacts of infectious ... #MDRTB #management ... #regimens #pharmacology
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
IDSA Summary of ... recommendations on drugs ... #MDRTB #management ... #pharmacology # ... ebm #idsa
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... drug use • Silicosis ... Treatment: Active ... TB #Diagnosis #Management ... #Treatment #ActiveTB